Tenosynovial giant cell tumor (TGCT) is a group of rare tumors that form in the joints. TGCT is not typically cancerous, but it can grow and damage surrounding structures. TGCTs are divided into types ...

(BPT) - TGCT stands for tenosynovial giant cell tumor, which is also sometimes called pigmented villonodular synovitis (PVNS) or giant cell tumor of the tendon sheath (GCT-TS). To most of us this may ...

Patients with TGCT are encouraged to honestly discuss their pain with their care teams. Patients with TGCTs, or tenosynovial giant cell tumors, often have to deal with pain and discomfort as a result ...

SynOx Therapeutics has completed subject enrolment in its multi-centre Phase III TANGENT trial of the humanised IgG1 monoclonal antibody (mAb) emactuzumab for the treatment of tenosynovial giant cell ...

Please provide your email address to receive an email when new articles are posted on . A reduced dosage and updated regimen are now available for the oral small molecule pexidartinib in the treatment ...

Vimseltinib becomes first authorised therapy for tenosynovial giant cell tumour in the EU The European Commission has approved ROMVIMZA (vimseltinib) for adult patients with symptomatic tenosynovial ...

Ono Pharmaceutical has claimed FDA approval for Romvimza as a treatment for tenosynovial giant cell tumour (TGCT), setting up a market tussle with Daiichi Sankyo. CSF-1R inhibitor Romvimza ...

Vimseltinib is the first and only therapy with marketing authorization for the treatment of TGCT in the European Union OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd.

More than 10 years of marijuana use is associated with the development of testicular germ cell tumor (TGCT), but the quality of the evidence is "low strength" and there is insufficient evidence to ...